The American Association for the Advancement of Science elects Lieberman as 2024 fellow
Click Here to Manage Email Alerts
Key takeaways:
- The American Association for the Advancement of Science elected orthopedic surgeon Jay R. Lieberman, MD, as a 2024 fellow.
- Lieberman was honored for his research in gene therapy, biologics and joint replacement.
The American Association for the Advancement of Science elected orthopedic surgeon Jay R. Lieberman, MD, as a 2024 fellow for his research in gene therapy and joint replacement, according to a press release.
The American Association for the Advancement of Science (AAAS) is an organization of scientists recognized for “extraordinary achievement in the advancement or application of science,” according to the release. The organization publishes the peer-reviewed academic journal Science.
Lieberman, chair and professor of orthopedic surgery at the Keck School of Medicine at the University of Southern California, has been recognized by the AAAS for his research in genetically manipulated stem cells and total joint replacement.
“We feel optimistic that our gene therapy could be used for a complex, elective procedure such as treating fractures that fail to heal, revision total joint replacement or failed spine fusion,” Lieberman said in the release.
Lieberman earned his medical degree from the Albany Medical College of Union University and completed his fellowship training in total joint replacement at Hospital for Special Surgery. The release noted he has published more than 300 biomedical manuscripts, book chapters and reviews, and served as principal investigator for several grants from the NIH.
“Many people who go into academic medicine are naturally curious,” Lieberman said. “Asking questions, rather than just accepting what others are doing, makes you a better surgeon.”